Understanding how phosphate affects bone and blood vessel mineralization
Phosphate signaling in biomineralization
This study is looking at how phosphate, a mineral important for strong bones and teeth, affects the way our cells work, especially those that help build bone, to find new ways to help people with conditions caused by too much or too little phosphate.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10652505 on NIH RePORTER |
What this research studies
This research investigates the role of inorganic phosphate in the process of biomineralization, which is essential for healthy bones and teeth. It aims to uncover the molecular mechanisms by which phosphate influences cellular functions and signaling pathways, particularly in osteogenic cells that contribute to bone formation. By studying how phosphate availability affects these processes, the research seeks to identify potential therapeutic targets for conditions related to abnormal phosphate levels, such as hyperphosphatemia and hypophosphatemia.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with genetic or acquired disorders affecting phosphate homeostasis, such as hyperphosphatemia, hypophosphatemia, or hypophosphatasia.
Not a fit: Patients without any disorders related to phosphate metabolism or those with unrelated conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for diseases caused by abnormal phosphate levels, improving bone and vascular health.
How similar studies have performed: Other research has shown promising results in understanding phosphate's role in cellular signaling, indicating that this approach may lead to significant advancements.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Napierala, Dobrawa — University of Pittsburgh at Pittsburgh
- Study coordinator: Napierala, Dobrawa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.